altair_8k-032709.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (date of earliest event reported): March 27,
2009
Altair Nanotechnologies
Inc.
|
(Exact
Name of Registrant as Specified in its
Charter)
|
Canada
|
|
1-12497
|
|
33-1084375
|
(State
or other jurisdiction of
|
|
(Commission
|
|
(IRS
Employer
|
incorporation
or organization)
|
|
File
Number)
|
|
Identification
No.)
|
204
Edison Way
|
|
|
Reno, NV
|
|
89502
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant's
Telephone Number, Including Area Code:
|
(801)
858-3750
|
N/A
|
(Former
name, former address, and formal fiscal year, if changed since last
report)
|
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (see General Instruction A.2.
below):
|
o
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)
|
Item
5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On
March 27, 2009, management of Altair Nanotechnologies Inc. (the “Company”)
received a copy of a letter from Michel Bazinet, a director of the Company,
tendering his resignation from the Board of Directors of the Company effective
June 3, 2009. Mr. Bazinet cited the need to devote more time to his
other business undertakings as being the reason for his resignation. Said
resignation was not due to any dispute or disagreement relating to the Company’s
operations, polices or practices.
On
March 31, 2009 The Board of Directors of Altair Nanotechnologies Inc. (the
“Company”) held a Special Meeting of the Board of Directors wherein among other
resolutions the Board resolved to accept the resignation of Michel Bazinet and
resolved, effective as of June 3, 2009, the Board of Directors shall be reduced
from the current eight members to seven members.
On
March 31, 2009 Doug Ellsworth, most recently serving the Company in the position
of Vice President for the Life Sciences & Performance Materials businesses,
has left the Company. Said departure was not due to any dispute or disagreement
relating to the Company’s operations, polices or practices.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
|
Altair
Nanotechnologies Inc.
|
|
|
|
|
Dated: April
1, 2009
|
By
/s/ John
Fallini
|
|
John
Fallini, Chief Financial
Officer
|
3